| Disease | attention deficit-hyperactivity disorder |
| Symptom | C0004941|behavioral symptoms |
| Sentences | 2 |
| PubMedID- 25606052 | Background: a wide range of evidence supports the methylphenidate (mph)-induced enhancement of prefrontal cortex (pfc) functioning and improvements in behavioral symptoms in patients with attention deficit hyperactivity disorder (adhd). |
| PubMedID- 22672778 | A reduced ponderal index has been associated with multiple diseases, including insulin resistance, obesity, behavioral symptoms of attention deficit hyperactivity disorder, coronary heart disease, and hypertension (fan et al. |
Page: 1